AIRLINK 65.69 Decreased By ▼ -0.21 (-0.32%)
BOP 5.68 Decreased By ▼ -0.01 (-0.18%)
CNERGY 4.62 Decreased By ▼ -0.03 (-0.65%)
DFML 23.05 Increased By ▲ 0.20 (0.88%)
DGKC 71.01 Increased By ▲ 0.31 (0.44%)
FCCL 20.74 Increased By ▲ 0.39 (1.92%)
FFBL 28.70 Decreased By ▼ -0.41 (-1.41%)
FFL 9.90 Decreased By ▼ -0.03 (-0.3%)
GGL 10.09 Increased By ▲ 0.01 (0.1%)
HBL 116.50 Increased By ▲ 1.25 (1.08%)
HUBC 130.00 Increased By ▲ 0.50 (0.39%)
HUMNL 6.64 Decreased By ▼ -0.06 (-0.9%)
KEL 4.55 Increased By ▲ 0.17 (3.88%)
KOSM 5.07 Increased By ▲ 0.05 (1%)
MLCF 37.50 Increased By ▲ 0.54 (1.46%)
OGDC 133.00 Increased By ▲ 1.80 (1.37%)
PAEL 22.76 Increased By ▲ 0.28 (1.25%)
PIAA 26.07 Decreased By ▼ -0.23 (-0.87%)
PIBTL 6.47 Decreased By ▼ -0.06 (-0.92%)
PPL 113.50 Increased By ▲ 1.38 (1.23%)
PRL 28.34 Decreased By ▼ -0.05 (-0.18%)
PTC 16.25 Increased By ▲ 0.14 (0.87%)
SEARL 57.73 Decreased By ▼ -0.56 (-0.96%)
SNGP 66.20 Increased By ▲ 0.51 (0.78%)
SSGC 11.09 Increased By ▲ 0.07 (0.64%)
TELE 8.95 Increased By ▲ 0.01 (0.11%)
TPLP 11.83 Increased By ▲ 0.30 (2.6%)
TRG 69.40 Increased By ▲ 0.16 (0.23%)
UNITY 23.79 Decreased By ▼ -0.16 (-0.67%)
WTL 1.40 Increased By ▲ 0.05 (3.7%)
BR100 7,331 Increased By 27.1 (0.37%)
BR30 24,151 Increased By 200.6 (0.84%)
KSE100 70,590 Increased By 256.2 (0.36%)
KSE30 23,197 Increased By 76.5 (0.33%)
World

WHO's COVAX initiative aims to start shipping 90mn COVID-19 vaccine doses to Africa in Feb

  • The roll-out of the AstraZeneca-Oxford vaccine is subject to the vaccine being listed for emergency use by WHO.
Published February 5, 2021

The World Health Organization said on Thursday its COVAX initiative aims to start shipping nearly 90 million COVID-19 vaccine doses to Africa in February.

About 320,000 doses of the Pfizer-BioNTech vaccine have been allocated to four African countries - Cabo Verde, Rwanda, South Africa and Tunisia, the WHO said in a statement.

The roll-out of the AstraZeneca-Oxford vaccine is subject to the vaccine being listed for emergency use by WHO.

The organization is currently reviewing the vaccine and the outcome of the review is expected soon.

Comments

Comments are closed.